Lori Jones

3.4k total citations · 1 hit paper
45 papers, 2.6k citations indexed

About

Lori Jones is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lori Jones has authored 45 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 11 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lori Jones's work include Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (12 papers). Lori Jones is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (12 papers). Lori Jones collaborates with scholars based in United States, Netherlands and Canada. Lori Jones's co-authors include Frank H. Valone, Paul F. Schellhammer, Celestia S. Higano, Robert M. Hershberg, Eric J. Small, John Nemunaitis, Charles H. Redfern, Ada M. Kruisbeek, L. Thomas Chin and Dan L. Longo and has published in prestigious journals such as Science, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Lori Jones

43 papers receiving 2.5k citations

Hit Papers

Placebo-Controlled Phase III Trial of Immunologic Therapy... 2006 2026 2012 2019 2006 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer
    2006 840 citations Eric J. Small, Paul F. Schellhammer et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Jones United States 21 1.5k 1.1k 589 549 343 45 2.6k
Diane J. Poole United States 19 1.1k 0.7× 931 0.9× 356 0.6× 541 1.0× 370 1.1× 28 2.0k
John Raemaekers Netherlands 34 515 0.3× 1.6k 1.5× 647 1.1× 411 0.7× 470 1.4× 117 3.8k
René Lafrenière Canada 20 1.8k 1.2× 1.5k 1.4× 162 0.3× 457 0.8× 311 0.9× 80 3.0k
Gerhard Fierlbeck Germany 30 793 0.5× 1.2k 1.1× 458 0.8× 813 1.5× 150 0.4× 97 3.2k
Leslie Popplewell United States 34 1.1k 0.7× 2.8k 2.6× 558 0.9× 1.1k 2.0× 302 0.9× 202 5.0k
Jeremy S. Abramson United States 40 1.0k 0.6× 3.3k 3.1× 375 0.6× 1.0k 1.8× 277 0.8× 237 5.5k
Sheila A. Prindiville United States 23 667 0.4× 992 0.9× 620 1.1× 871 1.6× 344 1.0× 51 2.6k
Anne Angiolillo United States 22 814 0.5× 915 0.9× 192 0.3× 523 1.0× 94 0.3× 76 2.7k
David M. Mintzer United States 22 402 0.3× 545 0.5× 477 0.8× 439 0.8× 441 1.3× 60 2.3k
Christina Chu United States 31 1.7k 1.1× 1.8k 1.7× 302 0.5× 536 1.0× 119 0.3× 102 3.8k

Countries citing papers authored by Lori Jones

Since Specialization
Citations

This map shows the geographic impact of Lori Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Jones more than expected).

Fields of papers citing papers by Lori Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Jones. The network helps show where Lori Jones may publish in the future.

Co-authorship network of co-authors of Lori Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Jones. A scholar is included among the top collaborators of Lori Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Jones. Lori Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Marshall, Emily Gard, Richard Buote, Agnes Grudniewicz, et al.. (2022). Influences on intentions for obstetric practice among family physicians and residents in Canada: an explorative qualitative inquiry. BMC Pregnancy and Childbirth. 22(1). 857–857. 3 indexed citations
3.
Jones, Lori, et al.. (2021). Dietary risk factors for esophageal cancer based on World Health Organization regions. Nutrition. 95. 111552–111552. 16 indexed citations
4.
Bleakley, Marie, Shelly Heimfeld, Lori Jones, et al.. (2014). Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells. Biology of Blood and Marrow Transplantation. 20(5). 705–716. 72 indexed citations
5.
Sheikh, Nadeem A. & Lori Jones. (2008). CD54 is a surrogate marker of antigen presenting cell activation. Cancer Immunology Immunotherapy. 57(9). 1381–1390. 83 indexed citations
6.
Small, Eric J., Paul F. Schellhammer, Celestia S. Higano, et al.. (2006). Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer. Journal of Clinical Oncology. 24(19). 3089–3094. 840 indexed citations breakdown →
7.
Delisle, Hélène, Janet Hatcher Roberts, Michelle L. Munro‐Kramer, Lori Jones, & Theresa W. Gyorkos. (2005). The role of NGOs in global health research for development. Health Research Policy and Systems. 3(1). 3–3. 83 indexed citations
8.
Burch, Patrick, Gary A. Croghan, Dennis A. Gastineau, et al.. (2004). Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen‐independent prostate cancer: A phase 2 trial. The Prostate. 60(3). 197–204. 156 indexed citations
9.
10.
Spatz, Linda, Vladimir Saenko, Lori Jones, et al.. (1997). Studies on the Structure, Regulation, and Pathogenic Potential of Anti-dsDNA Antibodies. Methods. 11(1). 70–78. 28 indexed citations
11.
Jones, Lori, Edgar R. Gonzalez, H. David Reines, & Jürgen Venitz. (1994). Assessment of 24-Hour Gastric pH Measurements in Trauma Patients Receiving Intravenous Famotidine by Intermittent Bolus versus Continuous Infusion Administration. Annals of Pharmacotherapy. 28(7-8). 841–844. 6 indexed citations
12.
Izon, David J., Lori Jones, Elizabeth E. Eynon, & Ada M. Kruisbeek. (1994). A molecule expressed on accessory cells, activated T cells, and thymic epithelium is a marker and promoter of T cell activation.. The Journal of Immunology. 153(7). 2939–2950. 11 indexed citations
13.
Izon, David J., John D. Nieland, Lori Jones, & Ada M. Kruisbeek. (1993). T Cell Tolerance and Antigen Presenting Cell Function in the Thymus. Advances in experimental medicine and biology. 329. 159–164. 2 indexed citations
14.
Kaufman, Bruce A., et al.. (1993). Megakaryoblastic leukemia presenting as a temporal bone granulocytic sarcoma. Journal of neurosurgery. 79(1). 128–131. 10 indexed citations
15.
Jones, Lori, David J. Izon, John D. Nieland, Peter S. Linsley, & Ada M. Kruisbeek. (1993). CD28-B7 interactions are not required for intrathymic clonal deletion. International Immunology. 5(5). 503–512. 46 indexed citations
16.
Kruisbeek, Ada M., John D. Nieland, & Lori Jones. (1992). Mechanism of Tolerance Induction. Advances in experimental medicine and biology. 323. 101–109. 1 indexed citations
17.
Gonzalez, Edgar R., et al.. (1992). Adjunctive Medications in Patients Receiving Thrombolytic Therapy: A Multicenter Prospective Assessment. Annals of Pharmacotherapy. 26(11). 1383–1384. 3 indexed citations
18.
Gonzalez, Edgar R., et al.. (1991). Prospective multicenter assessment of critical factors delaying hospital thrombolytic therapy. Journal of the American College of Cardiology. 17(2). A247–A247. 7 indexed citations
19.
Bryson, J. Scott, et al.. (1990). In vivo regulation of the murine syngeneic mixed lymphocyte reaction. Cellular Immunology. 129(1). 138–150. 3 indexed citations
20.
Nagarkatti, Prakash, et al.. (1988). Characterization of an endogenous Lyt 2+ T-suppressor-cell population regulating autoreactive T cells in vitro and in vivo. Cellular Immunology. 112(1). 64–77. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diane J. Poole Breakdown of academic impact, for papers by John Raemaekers Breakdown of academic impact, for papers by René Lafrenière Breakdown of academic impact, for papers by Gerhard Fierlbeck Breakdown of academic impact, for papers by Leslie Popplewell Breakdown of academic impact, for papers by Jeremy S. Abramson Breakdown of academic impact, for papers by Sheila A. Prindiville Breakdown of academic impact, for papers by Anne Angiolillo Breakdown of academic impact, for papers by David M. Mintzer Breakdown of academic impact, for papers by Christina Chu
Rankless by CCL
2026